We need your help with the largest and most comprehensive study of USP <797> and <800> compliance ever undertaken in the United States!

Dear Colleague,

The 2018 USP <797> & <800> Compliance Study, led by myself and sterile compounding expert and Study Co-Director, Kate Douglass, MS, RN, CRNI, is now open! The study gives you the opportunity to perform a complete USP <797> and <800> gap analysis or you have the option to answer questions related to just <797> or <800>, all from one login.

We believe that the information and insights gained from this year's Study will be very valuable to the industry. These results assist us in benchmarking our progress and to identify where additional resources and focus are required to continue to improve sterile compounding practice and patient safety. For that reason, we have committed ourselves to the Study and strongly encourage you to participate.

The 2018 USP Compliance Study uses a sophisticated, web-based Gap Analysis Tool that Kate and I developed and have been using for the last Six years. This tool is being made available at NO CHARGE to all study participants. It should be noted that ALL INDIVIDUAL FACILITY RESULTS ARE CONFIDENTIAL - ONLY AGGREGATE DATA WILL BE USED IN THE STUDY REPORT. 

In return for your participation, you will receive a highly detailed Action Plan that is automatically generated based on your answers to the survey. This Action Plan provides documentation that can be used to begin or continue sterile compounding practice improvements at your location. The survey takes 60 to 90 minutes to complete but does not need to be completed in one sitting. This year, the study team has also provided a PDF document of all the questions to facilitate offline data collection for those who might find this useful. This will be available for download after you have registered and completed the first 2 informational sections of the survey.

Please register for the Study today: www.797gaptool.com - Use Survey Code H797Rx

Study is NOW open and will remain open through June 30, 2018

Thank you in advance for your participation in The 2018 USP <797> and <800> Compliance Study. The results will help us to learn more about the successes and challenges relative to USP <797> and <800> compliance. With that insight, it becomes easier to target additional strategies to promote best-practice sterile compounding. The results of the Study will be published this fall.

Best regards,

Eric Kastango, RPh, MBA, FASHP

Study Co-Director, The 2018 USP <797> & <800> Compliance Study

PS. Please forward this email to your colleagues at other facilities. We are trying to encourage all Sterile Compounding facilities to participate in the Study. Thanks again.

Follow RXinsider on Social Media